EPHX2 and coronary artery disorder: Because PE and CHD share many risk factors and pathophysiological features and promoter methylation, that has been shown to affect EPHX2 expression [34], we hypothesised and investigated for the first time in our previous study that K55R polymorphism and promoter methylation levels in EPHX2 may be associated with PE.